Dr. Heather Wakelee is a Professor of Medicine and Chief of the Division of Oncology at Stanford University, Deputy Director of the Stanford Cancer Institute and Interim Medical Director of the Stanford Cancer Center. She is a graduate of Princeton University and Johns Hopkins University School of Medicine and completed her post-graduate training at Stanford University.  Dr. Wakelee has authored or co-authored over 200 medical articles on lung cancer and thymic malignancies and is involved in dozens of clinical trials. Her research focuses on many specific lung cancer subtypes defined by specific mutations in EGFR, ALK, ROS1, RET, BRAF and others.  Additionally she focuses on adjuvant therapy including immunotherapy and anti-angiogenesis agents and has active collaborations with colleagues focused in biomarkers and population science research.  Dr. Wakelee is the President of the International Association for the Study of Lung Cancer (IASLC); Co-Chair of the Thoracic Committee, Executive Committee member, and Stanford Principal Investigator for the Eastern Cooperative Oncology Group (ECOG-ACRIN), and she is a Fellow of the American Society of Clinical Oncology (FASCO).  She is passionate about mentorship and is proud of the many former trainees who are now working in faculty positions as lung cancer investigators and care providers.